Neurology

Headache & Migraine Disorders

Headache and migraine disorders are among the most prevalent neurological conditions, affecting millions worldwide and contributing to significant disability and economic burden. Migraines are characterized by recurrent, moderate-to-severe headache attacks, often accompanied by nausea, photophobia, phonophobia, and aura symptoms. Tension-type headaches, cluster headaches, and secondary headaches from underlying pathology also fall under this domain. Pathophysiology involves complex interactions between vascular, neuronal, and inflammatory pathways, including activation of trigeminovascular circuits, cortical spreading depression, and neurotransmitter imbalances. Diagnosis relies on clinical criteria, headache diaries, and exclusion of secondary causes via imaging or laboratory studies. Management is multifaceted, including acute pharmacotherapy (triptans, NSAIDs), preventive treatments (beta-blockers, CGRP inhibitors, anticonvulsants), lifestyle modification, and behavioral therapies. Emerging therapies focus on neuromodulation devices, CGRP-targeted therapies, and precision medicine approaches based on genetic and biomarker profiling. Patient education, lifestyle counseling, and identification of triggers play a critical role in reducing attack frequency and severity. Multidisciplinary approaches integrate neurologists, pain specialists, psychologists, and physical therapists to address both pain and associated disability. Research continues to investigate mechanisms of migraine chronification, novel therapeutics, and the impact of headache disorders on cognitive function and mental health. Advances in imaging, neurophysiology, and molecular biology are providing deeper insights, enhancing diagnosis, prevention, and individualized treatment strategies.